Tofacitinib repairs inflammation and mitochondrial dysregulation in GM-CSF-reprogrammed RA macrophages.

Saved in:
Bibliographic Details
Title: Tofacitinib repairs inflammation and mitochondrial dysregulation in GM-CSF-reprogrammed RA macrophages.
Authors: Satoeya N; Jesse Brown VA Medical Center, Chicago, IL, USA.; Department of Medicine, Division of Rheumatology, The University of Illinois Chicago, Chicago, IL, USA., Zack SR; Jesse Brown VA Medical Center, Chicago, IL, USA.; Department of Medicine, Division of Rheumatology, The University of Illinois Chicago, Chicago, IL, USA., Zoubi OA; Jesse Brown VA Medical Center, Chicago, IL, USA.; Department of Medicine, Division of Rheumatology, The University of Illinois Chicago, Chicago, IL, USA., Umar S; Department of Medicine, Division of Rheumatology, The University of Illinois Chicago, Chicago, IL, USA., Burgos A; Jesse Brown VA Medical Center, Chicago, IL, USA.; Department of Medicine, Division of Rheumatology, The University of Illinois Chicago, Chicago, IL, USA., Abdulrab S; Department of Medicine, Division of Rheumatology, The University of Illinois Chicago, Chicago, IL, USA., Zanotti B; Department of Microbiology and Immunology, Midwestern University, Downers Grove, IL, USA., Volin MV; Department of Microbiology and Immunology, Midwestern University, Downers Grove, IL, USA., Karam JA; Department of Orthopedic Surgery, University of Illinois College of Medicine, Chicago, IL, USA., Xia Y; Jesse Brown VA Medical Center, Chicago, IL, USA., Umali DC; Department of Medicine, Division of Rheumatology, The University of Illinois Chicago, Chicago, IL, USA., Arami S; Department of Medicine, Division of Rheumatology, The University of Illinois Chicago, Chicago, IL, USA., Al-Awqati M; Jesse Brown VA Medical Center, Chicago, IL, USA.; Department of Medicine, Division of Rheumatology, The University of Illinois Chicago, Chicago, IL, USA., Chang HT; Jesse Brown VA Medical Center, Chicago, IL, USA.; Department of Medicine, Division of Rheumatology, The University of Illinois Chicago, Chicago, IL, USA., O'Neill LAJ; School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College, Dublin, Ireland., Schett G; Department of Internal Medicine Rheumatology and Immunology Friedrich-Alexander Universität Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.; Deutsches Zentrum Immuntherapie, Friedrich-Alexander Universität Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany., Sweiss N; Department of Medicine, Division of Rheumatology, The University of Illinois Chicago, Chicago, IL, USA., Shahrara S; Jesse Brown VA Medical Center, Chicago, IL, USA. shahrara@uic.edu.; Department of Medicine, Division of Rheumatology, The University of Illinois Chicago, Chicago, IL, USA. shahrara@uic.edu.
Source: Cellular & molecular immunology [Cell Mol Immunol] 2026 Apr; Vol. 23 (4), pp. 417-431. Date of Electronic Publication: 2026 Mar 04.
Publication Type: Journal Article
Journal Info: Publisher: Chinese Society of Immunology Country of Publication: China NLM ID: 101242872 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2042-0226 (Electronic) Linking ISSN: 16727681 NLM ISO Abbreviation: Cell Mol Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2042-0226
DOI:10.1038/s41423-026-01395-x